Chemours Earnings Call Highlights Pricing Power, Deleveraging

Chemours Company ((CC)) has held its Q1 earnings call. Read on for the main highlights of the call.

Chemours struck an upbeat tone in its latest earnings call, as management highlighted results that topped expectations and showcased record profitability in its Thermal & Specialized Solutions unit. While executives acknowledged operational disruptions, demand timing issues and input cost pressures, they stressed stronger execution, portfolio progress and a clearer path to better performance in the second half.

TSS posts record quarter with pricing power

Thermal & Specialized Solutions delivered a standout first quarter, with net sales up 22% year over year and 28% sequentially on higher prices, stronger volumes and favorable mix. The segment posted record adjusted EBITDA and a 33% margin, while company‑wide pricing improved about 3% sequentially, underscoring Chemours’ pricing power in key refrigerant and specialty markets.

Titanium Technologies beats expectations despite volume drag

Titanium Technologies exceeded internal earnings expectations as disciplined global pricing and tight cost control offset softer volumes and a less favorable mix in some non‑Western markets. Management also signed a long‑term chlorine supply deal for the DeLisle site beginning in 2028, reinforcing its low‑cost chloride TiO2 position even as North American volumes lagged.

APM momentum builds in semiconductors and data centers

Advanced Performance Materials showed strengthening order books, particularly in high‑value semiconductor and data center applications, even though current results still reflect earlier disruptions. Management expects APM adjusted EBITDA to rise to $12 million–$18 million in the second quarter and is targeting $30 million–$40 million in the back half of 2026 as operations stabilize.

Balance sheet shored up through asset sale and refinancing

Chemours used proceeds from the accelerated sale of nearly all Kuan Yin properties to reduce debt by roughly $160 million and plans to harvest about $60 million more from the remaining parcel. The company also completed a $700 million refinancing that pushes maturities out to 2034, supports at least $100 million of second‑quarter free cash flow and trims future interest expense.

Operational discipline and the Chemours Business System

Management highlighted early benefits from the Chemours Business System, which promotes standardized processes, cost discipline and reliability across the portfolio. Combined with quota‑based allocation and successful December and April pricing actions, the framework is helping the company manage supply security, defend margins and navigate a choppy demand backdrop.

Outages and legacy issues weigh on APM

The quarter was not without setbacks, as the Washington Works outage and an earlier SPS Capstone line closure constrained volumes and added costs. Together these issues created an estimated $25 million headwind to adjusted EBITDA and depressed APM net sales versus last year, though management indicated the impact is transitory and factored into its outlook.

Demand timing and softer residential HVAC temper near term

Chemours pulled roughly $10 million of adjusted EBITDA into the first quarter from anticipated second‑quarter demand, which flatters the near‑term comparison. At the same time, residential HVAC equipment demand started the year slower than expected and weighed on aftermarket trends, limiting momentum in some TSS end markets heading into the spring season.

TiO2 volume softness and emerging cost pressures

Within Titanium Technologies, global TiO2 volumes slipped and mix worsened in select non‑Western markets, with North American sales called out as particularly soft. Adding to the challenge, management flagged tightening sulfur markets and broader raw‑material inflation tied to geopolitical tensions, which could pressure margins and drive further industry rationalization.

Free cash flow outlook reset on tax timing

The company now expects full‑year free cash flow conversion to be above 20%, slightly below the prior roughly 25% target, mainly because of tax effects linked to the Kuan Yin land sale. Management emphasized that the change reflects timing and presentation rather than operational weakness, with second‑quarter free cash flow still guided to at least $100 million.

Portfolio cleanup continues amid project cancellation

Chemours continues to refine its asset base, but not all initiatives are moving forward as planned, with a previously announced on‑site third‑party facility at DeLisle now terminated. The company still has several portfolio and operational changes underway, signaling ongoing efforts to streamline the footprint and sharpen focus on high‑return, core businesses.

Macro and local operational risks remain on the radar

Executives cautioned that global geopolitical tensions and localized operational issues could still disrupt plans, pointing to potential water‑use curtailments at Corpus Christi as an example. These risks have been incorporated into current guidance, but management acknowledged they represent downside scenarios investors should monitor alongside broader macro volatility.

Guidance signals confidence in Q2 and beyond

For the second quarter, Chemours guided to a 15%–20% sequential increase in consolidated net sales and adjusted EBITDA of $220 million–$250 million, with TSS/PFS expected to deliver $210 million–$225 million and TT $40 million–$50 million. The company reaffirmed full‑year net sales, EBITDA and capex guidance, while targeting leverage below 3.8x by 2026 and maintaining a path toward less than 3x over time.

Chemours’ latest call painted a picture of a company leaning on pricing power, balance sheet repair and operational rigor to offset outages, demand shifts and inflation. With record TSS performance, improving APM prospects and a clearer deleveraging roadmap, management argued that execution can carry the stock through near‑term noise, though macro and cost headwinds still warrant investor caution.